Micropoint Technologies

Executive Summary

Micropoint Technologies (Singapore) is a private medtech company that has developed proprietary microneedle platforms for transdermal drug delivery, cosmetics, and in-vitro diagnostics. Founded in 2008, the company specializes in dissolving microneedle patches and hollow microneedle hubs, enabling painless, high-volume administration of drugs and vaccines. With internal capabilities in stainless-steel, plastic, and polymeric microneedle manufacturing, Micropoint offers rapid prototyping, OEM production, and pilot-scale clinical batches, positioning itself as a versatile contract development and manufacturing organization (CDMO) for microneedle-based products. The firm targets the growing demand for needle-free delivery systems, particularly in vaccine distribution and dermatological treatments, leveraging its established 50–200 employee workforce and over a decade of operational experience. The company's Phase-2 stage indicates advancing clinical applications, with potential to capitalize on the global shift toward minimally invasive drug delivery. Although specific financials remain undisclosed, Micropoint's CDMO business model provides recurring revenue streams from pharmaceutical and cosmetic partners. Key competitive advantages include a diversified material portfolio and scalability from prototyping to commercial batches. The company's Singapore base offers access to Asian supply chains and biotech hubs. Near-term growth hinges on securing large-volume OEM contracts, regulatory approvals for its microneedle platforms, and partnerships for vaccine-delivery programs. With increasing adoption of microneedles in flu vaccines, insulin, and cosmetics, Micropoint is well-positioned to capture market share.

Upcoming Catalysts (preview)

• Q3 2026Strategic Partnership with a Major Vaccine Developer65% success
• Q4 2026FDA or CE Mark Approval for Dissolving Microneedle Patch Platform55% success
• Q2 2026Expansion of OEM Contracts with Cosmetic & Dermatology Brands75% success